Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 530

1.

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative.

Kasiske B, Cosio FG, Beto J, Bolton K, Chavers BM, Grimm R Jr, Levin A, Masri B, Parekh R, Wanner C, Wheeler DC, Wilson PW; National Kidney Foundation..

Am J Transplant. 2004;4 Suppl 7:13-53.

2.

The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.

Pennell P, Leclercq B, Delahunty MI, Walters BA.

Clin Nephrol. 2006 Nov;66(5):336-47.

PMID:
17140163
3.

Dyslipidemias in patients who have chronic kidney disease.

Farbakhsh K, Kasiske BL.

Med Clin North Am. 2005 May;89(3):689-99. Review.

PMID:
15755473
4.
5.
6.

Cardiovascular disease in patients with renal disease: the role of statins.

Fellström B, Holdaas H, Jardine AG, Svensson MK, Gottlow M, Schmieder RE, Zannad F; AURORA Study Group..

Curr Med Res Opin. 2009 Jan;25(1):271-85. doi: 10.1185/03007990802622064 . Review.

PMID:
19210158
7.

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients.

Kasiske BL; K/DOQI Dyslipidemia Work Group..

Am J Transplant. 2005 Jun;5(6):1576. No abstract available.

8.

National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.

Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS; National Kidney Foundation's Kidney Disease Outcomes Quality Initiative..

Pediatrics. 2003 Jun;111(6 Pt 1):1416-21.

PMID:
12777562
9.

Management of chronic kidney disease after renal transplantation: is it different from nontransplant patients?

Jiménez Alvaro S, Marcén R, Teruel JL, Fernández Rodríguez A, Pascual J, Galeano C, Villacorta J, Burgos FJ, Ortuño J.

Transplant Proc. 2009 Jul-Aug;41(6):2409-11. doi: 10.1016/j.transproceed.2009.06.107.

PMID:
19715935
10.

K/DOQI gets to the heart of managing dyslipidemias in patients with CKD.

Benner D.

Nephrol Nurs J. 2005 May-Jun;32(3):337-8.

PMID:
16035475
11.
12.

Impact of statins on cardiovascular outcomes in renal transplant recipients: a systematic review.

Maharjan N, Bedi U, Arora R, Bhandari S, Dahal P, Khosla S.

Am J Ther. 2011 May;18(3):e48-54. doi: 10.1097/MJT.0b013e3181cec203. Review.

PMID:
21048435
13.

[Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].

Ravera M, Paoletti E.

Ital Heart J Suppl. 2004 Jun;5(6):436-44. Review. Italian.

PMID:
15471148
14.

Statins for treatment of dyslipidemia in chronic kidney disease.

Shurraw S, Tonelli M.

Perit Dial Int. 2006 Sep-Oct;26(5):523-39. Review.

PMID:
16973506
15.

Lipid management in chronic kidney disease, hemodialysis, and transplantation.

Montague T, Murphy B.

Endocrinol Metab Clin North Am. 2009 Mar;38(1):223-34. doi: 10.1016/j.ecl.2008.11.004. Review.

PMID:
19217521
16.

Hyperlipidaemia in chronic kidney disease.

Chan CM.

Ann Acad Med Singapore. 2005 Jan;34(1):31-5. Review.

18.

Management of dyslipidemias in patients with diabetes and chronic kidney disease.

Molitch ME.

Clin J Am Soc Nephrol. 2006 Sep;1(5):1090-9. Epub 2006 Jul 26. Review.

19.

Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.

Ahmed MH, Khalil AA.

Saudi J Kidney Dis Transpl. 2010 Nov;21(6):1021-9. Review.

20.

Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.

Kanbay M, Turgut F, Covic A, Goldsmith D.

J Nephrol. 2009 Sep-Oct;22(5):598-609. Review.

PMID:
19809992

Supplemental Content

Support Center